Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

BUY
$2.59 - $4.65 $64,693 - $116,147
24,978 New
24,978 $87,000
Q1 2023

May 04, 2023

SELL
$3.81 - $6.76 $133 - $236
-35 Reduced 0.13%
26,605 $110,000
Q4 2022

Feb 09, 2023

BUY
$4.26 - $6.84 $115 - $184
27 Added 0.1%
26,640 $124,000
Q3 2022

Nov 10, 2022

BUY
$6.06 - $12.86 $47,201 - $100,166
7,789 Added 41.38%
26,613 $161,000
Q2 2022

Jul 26, 2022

BUY
$8.35 - $21.89 $157,180 - $412,057
18,824 New
18,824 $196,000
Q2 2021

Aug 11, 2021

SELL
$17.48 - $25.46 $6.6 Million - $9.62 Million
-377,809 Closed
0 $0
Q1 2021

May 13, 2021

BUY
$18.08 - $28.8 $1.99 Million - $3.16 Million
109,824 Added 40.98%
377,809 $8.65 Million
Q4 2020

Feb 10, 2021

BUY
$11.7 - $23.41 $1.16 Million - $2.31 Million
98,725 Added 58.33%
267,985 $5.85 Million
Q3 2020

Nov 12, 2020

BUY
$11.21 - $13.82 $1.9 Million - $2.34 Million
169,260 New
169,260 $1.99 Million

Others Institutions Holding CDXS

About CODEXIS, INC.


  • Ticker CDXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,494,100
  • Market Cap $335M
  • Description
  • Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...
More about CDXS
Track This Portfolio

Track Mirae Asset Global Investments Co., Ltd. Portfolio

Follow Mirae Asset Global Investments Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.